Home/Filings/5/0000914190-15-000079
5//SEC Filing

Arno Therapeutics, Inc 5

Accession 0000914190-15-000079

CIK 0001195116operating

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:22 PM ET

Size

8.9 KB

Accession

0000914190-15-000079

Insider Transaction Report

Form 5
Period: 2014-12-31
Proniuk Stefan
VP of Product Development
Transactions
  • Disposition to Issuer

    2012 Series B Warrants (right to buy)

    2014-10-288,3330 total
    Exercise: $2.40From: 2013-10-29Exp: 2014-10-31Common Stock (8,333 underlying)
  • Award

    2012 Series B Warrants (right to buy)

    2014-10-28+8,3338,333 total
    Exercise: $2.40From: 2013-10-29Exp: 2015-01-31Common Stock (8,333 underlying)
Holdings
  • Common Stock

    10,047
Footnotes (1)
  • [F1]The reported transaction resulted from the Issuer's unilateral extension of the expiration date of the outstanding warrant from 10/31/14 to 1/31/15. Such extension resulted in the deemed cancellation of the "originally" issued old warrant and the issuance of a replacement warrant. The Series B warrant was originally granted on 10/26/12.

Issuer

Arno Therapeutics, Inc

CIK 0001195116

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001195116

Filing Metadata

Form type
5
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:22 PM ET
Size
8.9 KB